newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces First Quarter 2026 Financial and Business Results

Q1 Revenue of $9.0 millionQ1 Income from Continuing Operations of $0.8 millionQ1 Thyroid volume year-over-year increase of 10%Q1 Thyroid revenue year-over-year increase of 12% PARSIPPANY, NJ, May 12, 2026 (GLOBE